Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background and aim Previous studies showed that renal dysfunction was associated with both a reduction in serum high-density lipoprotein (HDL) cholesterol concentration and increased circulating monocyte count. We aimed to investigate the effect of circulating monocyte to serum HDL cholesterol ratio (M/H ratio) on fatal and composite cardiovascular events, in an observational cohort study of chronic kidney disease (CKD) patients.Materials and methods A total of 340 subjects with stage 1-5 CKD were followed for a mean follow-up period of 33 (range 2-44) months and assessed for fatal and nonfatal CV events. M/H ratio was calculated for all patients. All-cause mortality and CVE were also analyzed in relation to M/H ratio.Results Monocyte/HDL cholesterol ratio was negatively correlated with estimated glomerular filtration rate (eGFR) (r = -0.43, P < 0.001). Notably, both fatal and combined fatal and nonfatal cardiovascular events were more common in patients having a M/H ratio in the third tertile was associated with a hazard ratio of 2.24 and 4.91, respectively, for fatal and composite cardiovascular events compared to being in the first tertile.Conclusion Monocyte/HDL cholesterol ratio was increased with decreasing eGFR in predialytic CKD patients. Most importantly, we report for the first time that an increased M/H ratio was cross-sectionally associated with a worse cardiovascular profile and arose as independent predictors of major cardiovascular events during follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
In the citing paper
“It was demonstrated that patients with hemodynamically significant stenosis (FFR ≤ 0.80) had higher MHR values, and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
Citations
Cites
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“In the presence of excessive metabolic and oxidative stress (such as in uremia), HDL might lose its protective effect and may behave as a pro-inflammatory molecule [12].”
BackgroundK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
(2003) · PubMed · Cited by 1,372
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890 · cited 1×
“Plaque macrophages account for the majority of leukocytes in plaques and are believed to be different from monocytes recruited from circulating blood [1].”
BackgroundAnsell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590 · cited 1×
“Inflammatory/anti-inflammatory properties of HDL also distinguish better patients that are favorably affected by simvastatin treatment [14].”
BackgroundAdhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundHigh-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 508 · cited 1×
“[5] showed in an experimental study that HDL and its major protein component—apolipoprotein A–I (apo A–I)—exhibit an antiinflammatory effect on human monocytes by inhibiting activation of CD11b.”
BackgroundSpeer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310 · cited 1×
“[16] showed that symmetric dimethyl arginine (SDMA) could modify the HDL particle to mimic a damage-associated molecular pattern that activates toll-like receptor-2, linking abnormal HDL to innate immunity, endothelial dysfunction, and hypertension.”
BackgroundThe macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundDysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
Yamamoto, S., Yancey, P. G., Ikizler, T. A., Jerome, W. G., Kaseda, R., Cox, B., Bian, A., Shintani, A., Fogo, A. B., Linton, M. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.013 · Cited by 199 · cited 2×
“[13] investigated the cellular cholesterol efflux and inflammatory response of macrophages exposed to HDL, in patients on hemodialysis treatment, compared to healthy controls.”
Background
Cited by
Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases
Ganjali, S., Gotto, A. M., Ruscica, M., Atkin, S. L., Butler, A. E., Banach, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27028 · Cited by 313
“94) compared with patients with low MHR (Kanbay et al., 2014).”
BackgroundMethodResultInfluentialCanpolat, U., Çetin, E. H., Cetin, S., Aydin, S., Akboga, M. K., Yayla, C., Turak, O., Aras, D., & Aydogdu, S. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615594002 · Cited by 213
“In a recent study, Kanbay et al14 combined the circulating monocyte count and serum HDL-C in a proportion, as ‘‘MHR,’’ which was found as cross-sectionally associated with poor cardiovascular prognosis and arose as independent predictor of major cardiovascular events in patients with chronic kidney…”
BackgroundSelf-citationCetin, M. S., Ozcan Cetin, E. H., Kalender, E., Aydin, S., Topaloglu, S., Kisacik, H. L., & Temizhan, A. (2016) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2016.02.023 · Cited by 194
Disorders of Lipid Metabolism in Chronic Kidney Disease
Bulbul, M. C., Dağel, T., Afşar, B., Ulusu, N. N., Kuwabara, M., Covic, A. C., & Kanbay, M. (2018) · Blood Purification · doi:10.1159/000488816 · Cited by 163
Self-citationCanpolat, U., Aytemir, K., Yorgun, H., Şahiner, L., Kaya, E. B., Çay, S., Topaloğlu, S., Aras, D., & Oto, A. (2015) · Europace · doi:10.1093/europace/euu291 · Cited by 130
“In a recent study,Kanbayet al.(9) combined the circulating monocyte count and serum HDL cholesterol in a fraction, as ‘M/H ratio’, which was found to be cross-sectionally associated with a poor cardiovascular prognosis and arose as an independent predictor of major cardiovascularevents inpatientswith chronic kidneydis…”
Background
Metadata
- Authors
- Kanbay, M., Solak, Y., Unal, H. U., Kurt, Y. G., Gok, M., Cetinkaya, H., Karaman, M., Oguz, Y., Eyileten, T., Vural, A., Covic, A., Goldsmith, D., Turak, O., & Yilmaz, M. I.
- Affiliations
- Istanbul Medeniyet University (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Spitalul Clinic Dr. C. I. Parhon (RO)
- St Thomas' Hospital (GB)
- Türkiye Yüksek İhtisas Hastanesi (TR)
- Corresponding author
- Kanbay, Mehmet
- Venue
- International Urology and Nephrology
- Published
- 2014-05-23
- Volume
- 46
- Issue
- 8
- Pages
- 1619-1625
- ISSN
- 0301-1623 (ISSN-L)
- 1573-2584
- OpenAlex
- W2035731392
- Cited by
- 276
- References
- 17
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 32 · 2023: 34 · 2022: 30 · 2021: 34 · 2020: 31 · 2019: 27 · 2018: 18 · 2017: 13 · 2016: 17 · 2015: 6
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Urology and Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- monocyte count, HDL cholesterol, chronic kidney disease, cardiovascular events, all-cause mortality, estimated glomerular filtration rate, cardiovascular risk prediction
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Leukocyte Count, Cholesterol, HDL, Male, Middle Aged, Monocytes, Myocardial Infarction, Prospective Studies, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. https://app.cochat.ai/papers/10.1007/s11255-014-0730-1
- The paper
- Kanbay, M., Solak, Y., Unal, H. U., Kurt, Y. G., Gok, M., Cetinkaya, H., Karaman, M., Oguz, Y., Eyileten, T., Vural, A., Covic, A., Goldsmith, D., Turak, O., & Yilmaz, M. I. (2014). Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. International Urology and Nephrology. https://doi.org/10.1007/s11255-014-0730-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.